Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kartik Konduri

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Advances in Therapy|October 1, 2023
Biomarker Testing for Actionable Alterations in NSCLC-Perspectives from US-Based Academic and Community Oncologists: A PodcastWade T Iams, Kartik Konduri
Therapeutic Advances in Medical Oncology|January 10, 2012
Epithelial-mesenchymal transition in pulmonary carcinosarcoma: case report and literature reviewVibha T Thomas, Stacy Hinson, Kartik Konduri
Cureus|August 29, 2022
Locally Advanced Inflammatory Myofibroblastic Tumor Treated With Targeted Therapy: A Case Report and Literature ReviewCharis Durham, Matthew Clemons, Alwin Alias, et al.
Proceedings (Baylor University. Medical Center)|January 18, 2011
Ectopic adrenocorticotropic hormone syndrome: a diagnostic challenge and review of the literatureYanjun Ma, Cristi Aitelli, Robin W Dobson, et al.
Proceedings (Baylor University. Medical Center)|January 18, 2011
Chest wall chondrosarcomaErin Capps, S Michelle Shiller, Scott Cheek, et al.
Lung Cancer (Amsterdam, Netherlands)|June 4, 2014
BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenibSara D Robinson, Joyce A O'Shaughnessy, C Lance Cowey, et al.
Proceedings (Baylor University. Medical Center)|January 18, 2011
Recurrent thyroid cancer with changing histologic featuresS Michelle Shiller, Kartik Konduri, Leeanne K Harshman, et al.
Clinical Lymphoma|March 30, 2005
Immunoglobulin M myeloma: evaluation of molecular features and cytokine expressionKartik Konduri, Surinder S Sahota, Gavin Babbage, et al.
Frontiers in Oncology|February 12, 2021
<i>nab</i>-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled AnalysisCorey J Langer, Ajeet Gajra, Cesare Gridelli, et al.
Frontiers in Oncology|August 9, 2018
<i>nab</i>-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLCCorey J Langer, Edward S Kim, Eric C Anderson, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Advances in Therapy|October 1, 2023
Biomarker Testing for Actionable Alterations in NSCLC-Perspectives from US-Based Academic and Community Oncologists: A PodcastWade T Iams, Kartik Konduri
Therapeutic Advances in Medical Oncology|January 10, 2012
Epithelial-mesenchymal transition in pulmonary carcinosarcoma: case report and literature reviewVibha T Thomas, Stacy Hinson, Kartik Konduri
Cureus|August 29, 2022
Locally Advanced Inflammatory Myofibroblastic Tumor Treated With Targeted Therapy: A Case Report and Literature ReviewCharis Durham, Matthew Clemons, Alwin Alias, et al.
Proceedings (Baylor University. Medical Center)|January 18, 2011
Ectopic adrenocorticotropic hormone syndrome: a diagnostic challenge and review of the literatureYanjun Ma, Cristi Aitelli, Robin W Dobson, et al.
Proceedings (Baylor University. Medical Center)|January 18, 2011
Chest wall chondrosarcomaErin Capps, S Michelle Shiller, Scott Cheek, et al.
Lung Cancer (Amsterdam, Netherlands)|June 4, 2014
BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenibSara D Robinson, Joyce A O'Shaughnessy, C Lance Cowey, et al.
Proceedings (Baylor University. Medical Center)|January 18, 2011
Recurrent thyroid cancer with changing histologic featuresS Michelle Shiller, Kartik Konduri, Leeanne K Harshman, et al.
Clinical Lymphoma|March 30, 2005
Immunoglobulin M myeloma: evaluation of molecular features and cytokine expressionKartik Konduri, Surinder S Sahota, Gavin Babbage, et al.
Frontiers in Oncology|February 12, 2021
<i>nab</i>-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled AnalysisCorey J Langer, Ajeet Gajra, Cesare Gridelli, et al.
Frontiers in Oncology|August 9, 2018
<i>nab</i>-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLCCorey J Langer, Edward S Kim, Eric C Anderson, et al.
Pageof 2